INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO)
인돌아민 2,3-디옥시게나제 (IDO)의 효소적 활성을 조절 또는 억제하는 화합물, 상기 화합물을 포함하는 제약 조성물 및 본 발명의 화합물을 이용하여 증식성 장애, 예컨대 암, 바이러스 감염 및/또는 염증성 장애를 치료하는 방법이 개시된다. There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said comp...
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | English Korean |
| Published |
18.11.2015
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 인돌아민 2,3-디옥시게나제 (IDO)의 효소적 활성을 조절 또는 억제하는 화합물, 상기 화합물을 포함하는 제약 조성물 및 본 발명의 화합물을 이용하여 증식성 장애, 예컨대 암, 바이러스 감염 및/또는 염증성 장애를 치료하는 방법이 개시된다.
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention. |
|---|---|
| AbstractList | 인돌아민 2,3-디옥시게나제 (IDO)의 효소적 활성을 조절 또는 억제하는 화합물, 상기 화합물을 포함하는 제약 조성물 및 본 발명의 화합물을 이용하여 증식성 장애, 예컨대 암, 바이러스 감염 및/또는 염증성 장애를 치료하는 방법이 개시된다.
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention. |
| Author | CHEN LIBING MARKWALDER JAY A BALOG JAMES AARON HUANG AUDRIS HART AMY C CHEN BIN SEITZ STEVEN P |
| Author_xml | – fullname: SEITZ STEVEN P – fullname: CHEN BIN – fullname: BALOG JAMES AARON – fullname: HART AMY C – fullname: MARKWALDER JAY A – fullname: HUANG AUDRIS – fullname: CHEN LIBING |
| BookMark | eNrjYmDJy89L5WTQ9_Tz8HTyDPEPClbwd1Pw9HPx93F19PX0c1Uw0jHWdfH0j4h0d_VzDHZV0PB08dfkYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBoamBoZGFhaWho7GxKkCAGQ6KBo |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 인돌아민 2,3-디옥시게나제 (IDO)의 억제제 |
| ExternalDocumentID | KR20150128891A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20150128891A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:52:37 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20150128891A3 |
| Notes | Application Number: KR20157028056 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151118&DB=EPODOC&CC=KR&NR=20150128891A |
| ParticipantIDs | epo_espacenet_KR20150128891A |
| PublicationCentury | 2000 |
| PublicationDate | 20151118 |
| PublicationDateYYYYMMDD | 2015-11-18 |
| PublicationDate_xml | – month: 11 year: 2015 text: 20151118 day: 18 |
| PublicationDecade | 2010 |
| PublicationYear | 2015 |
| RelatedCompanies | BRISTOL-MYERS SQUIBB COMPANY |
| RelatedCompanies_xml | – name: BRISTOL-MYERS SQUIBB COMPANY |
| Score | 2.9707625 |
| Snippet | 인돌아민 2,3-디옥시게나제 (IDO)의 효소적 활성을 조절 또는 억제하는 화합물, 상기 화합물을 포함하는 제약 조성물 및 본 발명의 화합물을 이용하여 증식성 장애, 예컨대 암, 바이러스 감염 및/또는 염증성 장애를 치료하는 방법이 개시된다.
There are disclosed... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151118&DB=EPODOC&locale=&CC=KR&NR=20150128891A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUeMHmiWaRRMXZGxQHoiBtZOKrGQgwSfCSpcYzSAy47_vrQHlibe2l1w_kt_9rh_XA7iRUhJHKWLFcV1aDrrgFtJwZCHZSOVW7InSKVm6QbX96jyP3FEOPlexMPqf0B_9OSIiSiLeU22v5_-HWFS_rVyUondsmj36gwY1l7tjpC90mE3aarCeoMIzPa_RCc0g1LLMFpN6ubkF2-hI1zI8sGEri0uZr5OKfwA7PdSXpIeQ-5gVYM9b5V4rwG53eeWNxSX6FkdQ4kGbt_hAhH1D-AYPqHhhzS4PmGHfVyzKxejtiQXNPjNuORV3x3Dts4HXtrDn8d9Ex51wfZiVE8gns0SdglG1ZdmWMXGn9tQhMdpX5ci6eiCTmu1OovgMips0nW8WX8B-Vs0i7MqkCPn061tdItWm0ZVeoV9aHnzg |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUeMH6hLNookLMjYoD8TA2rkKa8mYZj4RVrrEaIDIjP--3QLKE29NL7l-JL_7XT_uDuBGCIEsKZGRJC1hWMoFNxQNx4YiGyHtujmWeUkWnzW8F-s5sqMCfK5iYfI8oT95ckSFKKHwnub2ev5_iYXzv5WLavyuumaPbtjG-vJ0rOhLOcw67rbJgGPu6I7T7gU6C3JZZotRq9bZgm3lZDczPJDXbhaXMl8nFXcfdgZK3zQ9gMLHrAwlZ1V7rQy7_vLJWzWX6FscQpUyj3ZpyIOhxl2NMsz7pONTRjTzvm5gyqO3J8I6Q6LdUszvjuDaJaHjGWrk0d9CR71gfZr1YyhOZ1N5AlrDFDVTJMiemBMLJcq-Sku05AMaN017HCenUNmk6Wyz-ApKXuj3R33Keuewl4myaLsaqkAx_fqWF4p20_gy361fYJR_0w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INHIBITORS+OF+INDOLEAMINE+2%2C3-DIOXYGENASE+%28IDO%29&rft.inventor=SEITZ+STEVEN+P&rft.inventor=CHEN+BIN&rft.inventor=BALOG+JAMES+AARON&rft.inventor=HART+AMY+C&rft.inventor=MARKWALDER+JAY+A&rft.inventor=HUANG+AUDRIS&rft.inventor=CHEN+LIBING&rft.date=2015-11-18&rft.externalDBID=A&rft.externalDocID=KR20150128891A |